Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Perceptive LS (A), LLC — Lyra Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Perceptive LS (A), LLC

Perceptive LS (A), LLC

10% owner at Lyra Therapeutics, Inc. · on record since Apr 30, 2020

Insider trading activity of Perceptive LS (A), LLC

Transactions on record: 2; since Jun 2, 2023

Open-market buys: 1; $9M

Open-market sells: 0

Companies traded: 1; last filing Jun 2, 2023

Figures computed from official regulatory filings — methodology.

Companies where Perceptive LS (A), LLC has traded

Lyra Therapeutics, Inc.2 tx · $9M · Jun 2, 2023

Track record of Perceptive LS (A), LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Perceptive LS (A), LLC

Co-insiders of Perceptive LS (A), LLC

ALTMAN MICHAEL SETHLyra Therapeutics, Inc.
ANDERSON EDWARD TLyra Therapeutics, Inc.
Bishop John ELyra Therapeutics, Inc.
Cavalier JasonLyra Therapeutics, Inc.
DAMORE RICHARD ALyra Therapeutics, Inc.
EDELMAN JOSEPHLyra Therapeutics, Inc.
Edgerly-Pflug LauraLyra Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Elsey R DonLyra Therapeutics, Inc.

Flint Jonathan ALyra Therapeutics, Inc.

LANGER ROBERTLyra Therapeutics, Inc.

Levy GuyLyra Therapeutics, Inc.

MCGUIRE TERRANCELyra Therapeutics, Inc.

MERRIFIELD C ANNLyra Therapeutics, Inc.

MOTT RICHARD WLyra Therapeutics, Inc.

NBVM GP, LLCLyra Therapeutics, Inc.

Nelson Pamela E.Lyra Therapeutics, Inc.

Nieman RichardLyra Therapeutics, Inc.

North Bridge Venture Management VI, L.P.Lyra Therapeutics, Inc.

North Bridge Venture Management V, L.P.Lyra Therapeutics, Inc.

NORTH BRIDGE VENTURE PARTNERS V A LPLyra Therapeutics, Inc.

NORTH BRIDGE VENTURE PARTNERS V-B LPLyra Therapeutics, Inc.

North Bridge Venture Partners VI L PLyra Therapeutics, Inc.

Noyes CorinneLyra Therapeutics, Inc.

Palasis MariaLyra Therapeutics, Inc.

PERCEPTIVE ADVISORS LLCLyra Therapeutics, Inc.

PERCEPTIVE LIFE SCIENCES MASTER FUND LTDLyra Therapeutics, Inc.

Polaris Venture Management Co IV LLCLyra Therapeutics, Inc.

Polaris Venture Management Co. V, L.L.C.Lyra Therapeutics, Inc.

POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV LPLyra Therapeutics, Inc.

Polaris Venture Partners Entrepreneurs' Fund V, L.P.Lyra Therapeutics, Inc.

Polaris Venture Partners Founders' Fund V, L.P.Lyra Therapeutics, Inc.

POLARIS VENTURE PARTNERS IV LPLyra Therapeutics, Inc.

Polaris Venture Partners Special Founders' Fund V, L.P.Lyra Therapeutics, Inc.

Polaris Venture Partners V, L.P.Lyra Therapeutics, Inc.

Poukalov KonstantinLyra Therapeutics, Inc.

Richard Robert E.Lyra Therapeutics, Inc.

Roberts CarmichaelLyra Therapeutics, Inc.

Smith W BradfordLyra Therapeutics, Inc.

snyderman nancy lynn MDLyra Therapeutics, Inc.

Soleus Capital Group, LLCLyra Therapeutics, Inc.

Soleus Capital, LLCLyra Therapeutics, Inc.

Soleus Capital Master Fund, L.P.Lyra Therapeutics, Inc.

Soleus PE GP I, LLCLyra Therapeutics, Inc.

Soleus Private Equity Fund I, L.P.Lyra Therapeutics, Inc.

Soleus Private Equity GP I, LLCLyra Therapeutics, Inc.

TOBIN JAMES RLyra Therapeutics, Inc.

Waksal HarlanLyra Therapeutics, Inc.

WHITESIDES GEORGE MLyra Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Lyra Therapeutics, Inc.	Jun 2, 2023	Buy	3,610,832	2.49 USD	$9M	SEC
Lyra Therapeutics, Inc.	Jun 2, 2023	BuyD	1,805,416	—	—	SEC